{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:39:18Z","timestamp":1779104358314,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1124\/jpet.123.001644","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T16:15:12Z","timestamp":1689610512000},"page":"111-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["All Eyes on Me, Please: Ocular Palonosetron for the Cancer Patient with Nausea and Vomiting"],"prefix":"10.1016","volume":"386","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5678-6175","authenticated-orcid":false,"given":"Giorgio","family":"Minotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1124\/jpet.123.001644_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00520-018-4131-3","article-title":"CINV: still troubling patients after all these years","volume":"26","author":"Aapro","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1124\/jpet.123.001644_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175379","article-title":"Gastrointestinal inflammation plays a critical role in chemotherapy-induced nausea and vomiting","volume":"936","author":"Chen","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.123.001644_bib3","article-title":"Chemotherapy-induced nausea and vomiting: pathogenesis, recommendations, and new trends","volume":"26","author":"Gupta","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"10.1124\/jpet.123.001644_bib4","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1007\/s00221-014-3961-6","article-title":"Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration","volume":"232","author":"Kenward","year":"2014","journal-title":"Exp Brain Res"},{"key":"10.1124\/jpet.123.001644_bib5","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1200\/JCO.1985.3.10.1379","article-title":"Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin","volume":"3","author":"Kris","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1124\/jpet.123.001644_bib6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1124\/jpet.122.001444","article-title":"Ocular administration of palonosetron in the prevention of cisplatin-induced nausea and vomiting","volume":"384","author":"Levijoki","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001644_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/ecc.12618","article-title":"Patients\u2019 perception of chemotherapy side effects: expectations, doctor-patient communication and impact on quality of life - an Italian survey","volume":"26","author":"Lorusso","year":"2017","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1124\/jpet.123.001644_bib8","article-title":"Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis","volume":"11","author":"Piechotta","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/jpet.123.001644_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00520-018-4464-y","article-title":"ASCO, NCCN, MASCC\/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients","volume":"27","author":"Razvi","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1124\/jpet.123.001644_bib10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1124\/jpet.110.166181","article-title":"The antiemetic 5-HT3 receptor antagonist palonosetron inhibits substance P-mediated responses in vitro and in vivo","volume":"335","author":"Rojas","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001644_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejphar.2009.10.002","article-title":"Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function","volume":"626","author":"Rojas","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.123.001644_bib12","doi-asserted-by":"crossref","first-page":"E217","DOI":"10.1097\/NCC.0000000000000694","article-title":"Recent advances in antiemetics: new formulations of 5-HT3 receptor antagonists in adults","volume":"43","author":"Smith","year":"2020","journal-title":"Cancer Nurs"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524170541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524170541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.123.001644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:29:49Z","timestamp":1739971789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524170541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0022356524170541"],"URL":"https:\/\/doi.org\/10.1124\/jpet.123.001644","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"All Eyes on Me, Please: Ocular Palonosetron for the Cancer Patient with Nausea and Vomiting","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.123.001644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}